Lack of Evidence of Lower 30-day All-cause Readmission in Medicare Beneficiaries With Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone.
Document Type
Journal Article
Publication Date
1-15-2017
Journal
International Journal of Cardiology
Volume
227
DOI
10.1016/j.ijcard.2016.11.006
Keywords
Alabama; Female; Heart Failure; Humans; Insurance Benefits; Male; Medicare; Mineralocorticoid Receptor Antagonists; Patient Readmission; Risk Factors; Spironolactone; Stroke Volume; Treatment Outcome; United States
APA Citation
Lam, P., Dooley, D., Inampudi, C., Arundel, C., Fonarow, G., Butler, J., Wu, W., Blackman, M., Anker, M., Deedwania, P., White, M., Prabhu, S., Morgan, C., Love, T., Aronow, W., Allman, R., & Ahmed, A. (2017). Lack of Evidence of Lower 30-day All-cause Readmission in Medicare Beneficiaries With Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone.. International Journal of Cardiology, 227 (). http://dx.doi.org/10.1016/j.ijcard.2016.11.006
Peer Reviewed
1
